Mercury Systems, Inc. (MRCY), the Andover, Massachusetts-based aerospace and defense electronics firm, has drawn attention from investors wondering if it can reach a fresh all-time high. The stock hit a 52-week peak of $128.45 early in July 2026 before pulling back, recently trading near $86. That pullback has put the spotlight on the $130 milestone, a round number that would mark a new record and aligns closely with the highest analyst target of $131.
Unlike levels already cleared, $130 still feels out of reach at current prices. From around $86, the shares would need roughly a 51% advance, which is substantial yet plausible given recent operational improvements. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Mercury Systems builds secure, rugged computing and signal-processing hardware for defense contractors, the U.S. government, and commercial aerospace clients. Its solutions turn commercial chips into mission-critical systems for radar, electronic warfare, autonomy, and command-and-control applications. The company serves as a sole-source supplier on hundreds of active defense programs, including the F-35, Aegis, and Patriot platforms.
Latest quarterly results showed progress on the turnaround. Fourth-quarter fiscal 2026 revenue climbed about 6% year over year, while bookings jumped more than 90% to a record $660 million, producing a book-to-bill ratio above 2.0. Backlog topped $1.9 billion, up roughly 38% from a year earlier, providing a solid pipeline of work ahead.
The core bullish argument centers on rising demand for onboard computing power in modern military systems. Aircraft, ships, and vehicles are evolving into mobile sensor and computing hubs, and Mercury supplies the secure processing technology that supports this shift.
Margin improvement is another important element. After adjusted EBITDA margins dipped to around 1% in fiscal 2024, the company has restored profitability, posting an adjusted EBITDA margin of about 16.7% in the most recent quarter. Management is also moving the portfolio toward higher-margin production work, which should support earnings growth over time.
The large backlog adds visibility. Continued conversion of bookings into revenue alongside margin expansion could drive EPS growth that justifies higher valuations.
Valuation remains a frequent concern. After a strong two-year advance, the shares trade at a premium multiple that offers little margin for error. Some models suggest the current price already reflects substantial future growth, raising the bar for delivery.
Customer concentration adds another layer of risk, with a sizable portion of revenue tied to a handful of large defense primes. The company also relies on a limited set of suppliers for advanced components such as FPGAs and ASICs, so any disruption could affect results.
Analyst views are not uniform. Goldman Sachs maintains a Sell rating with a $78 target, about 10% below recent levels, citing doubts about near-term earnings and valuation.
The broader analyst community leans constructive, though targets vary. The consensus is a Buy, with an average twelve-month target near $110 to $116. Individual forecasts range from a low of $68–$78 to a high of $131. Recent notes include Guggenheim’s Buy initiation at $115, while Baird, Canaccord Genuity, RBC Capital, and Truist Securities hold constructive ratings with targets between $120 and $130.
The wide gap between the $131 high and $78 low highlights real differences of opinion. Reaching $130 would require the bullish scenario of sustained double-digit revenue growth and ongoing margin expansion to materialize while sidestepping the risks highlighted by skeptics.
Technically, the drop from $128.45 to the mid-$80s has left overhead supply. The $128–$131 zone now acts as resistance that needs to be cleared for a sustained breakout. On the downside, the $78–$80 area has provided support recently and lines up with the most cautious targets.
For $130 to come into view, the stock would likely need to reclaim and hold above $100 before testing the prior high near $128. A decisive close above $131 would signal a breakout, whereas stalling at that level could leave shares range-bound.
Traders following Mercury Systems can also turn to AI Daily Buy/Sell Signals, a tool that uses artificial intelligence to continuously monitor thousands of stocks and ETFs. The system generates Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. This can help traders discover new opportunities, monitor existing positions, and identify shifting market trends more efficiently than manual screening alone. For investors watching whether MRCY can approach $130, such signals offer one more lens for timing entries and managing risk.
In my own process, I often cross-check ideas with Tickeron’s suite of AI-driven platforms to get a broader view of sector trends and signal consistency. These tools help surface patterns that might otherwise take hours to identify manually, and I find them especially useful when evaluating defense names like MRCY amid shifting order flow and margin dynamics.
A move to $130 is ambitious but within the realm of possibility. Mercury Systems enters this period with record bookings, an expanding backlog, and a recovering margin profile—elements that underpin the bullish case. The strongest support comes from the company’s ability to turn rising defense demand into contracted revenue.
Risks remain material, however. A premium valuation, customer and supplier concentration, and at least one prominent Sell rating all warrant caution. The $130 level sits directly above resistance from the prior high, so a decisive catalyst—continued bookings strength, faster margin gains, or raised guidance—would likely be needed to break through and hold. Investors should track order flow, profitability trends, and the stock’s ability to reclaim $100 and $128 before concluding that $130 is within reach.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
MRCY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 38 of 44 cases where MRCY's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 86%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where MRCY's RSI Indicator exited the oversold zone, 19 of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 68%.
The Momentum Indicator moved above the 0 level on September 16, 2026. You may want to consider a long position or call options on MRCY as a result. In 59 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 69%.
The Moving Average Convergence Divergence (MACD) for MRCY just turned positive on September 15, 2026. Looking at past instances where MRCY's MACD turned positive, the stock continued to rise in 34 of 47 cases over the following month. The odds of a continued upward trend are 72%.
Following a +7.68% 3-day Advance, the price is estimated to grow further. Considering data from situations where MRCY advanced for three days, in 227 of 315 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
MRCY moved below its 50-day moving average on August 18, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for MRCY crossed bearishly below the 50-day moving average on August 20, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 15 of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 79%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MRCY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.
The Aroon Indicator for MRCY entered a downward trend on September 17, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 2 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 55 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating steady price growth. MRCY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 97 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.504) is normal, around the industry mean (6.263). P/E Ratio (0.000) is within average values for comparable stocks, (55.218). MRCY's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.867). Dividend Yield (0.000) settles around the average of (0.017) among similar stocks. P/S Ratio (5.274) is also within normal values, averaging (18.155).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of real-time digital signal processing computer systems
Industry AerospaceDefense